Patients scheduled to undergo elective lower extremity surgery with spinal anesthesia in the Imam Hossein Hospital for less than three hours were eligible. Inclusion criteria were: aged 18-70 years, ASA I or II, spinal cord length between 66 and 76 cm (male) or 56 and 66 cm (female). The spinal cord length was measured by a designated staff member using the C7 spinous process to the sacral hiatus (in a sitting position, face forward and flat legs in rest on the operating table).
Exclusion criteria were: ASA III, and IV, cardiac-respiratory-renal insufficiency or underlying hepatic failure, inadequate linguistic contact, and inability to cooperate in order to determine the block level, smoker or opium user, spinal diseases or vertebral deformities, spinal column length out of the defined range, neurologic deficits or coagulopathies and contraindications for spinal anesthesia. No premedication was given before surgery.
Routine monitoring and primary records of the vital signs were performed. Patients were randomly allocated to receive one of three fluid types: normal saline (NS); Ringer (R) (Samen, Iran); or hydroxyethyl starch 130/0.4 (HES) (trade name Voluven, Frezinus, Germany).
All patients fasted for eight hours before surgery. Fluids were infused for 10-15 min in the operating room's waiting area prior to spinal anesthesia by an anesthesiologist. Volumes infused were 10 mL/kg for NS and R, and 5 mL/kg for HES. Baseline values of heart rate, noninvasive arterial blood pressure, and O2 saturation were recorded on arrival in the operating room.
A second anesthesiologist, blinded to the preload fluid type administered, performed the spinal anesthesia at the third lumbar interspace (L3– 4), using the midline approach, with the patients in the right lateral decubitus position, and assessed the sensory and motor levels. Local anesthesia was 2 mL of lidocaine 2% with a 25-gauge needle, and spinal anesthesia was performed via a 25-gauge Whitacre spinal needle (BD Whitacre needle, BD Medical System, New Jersey, USA), with3mL (15mg) hyperbaric bupivacaine at 0.2 mL/sec, after ensuring the correct needle position and CSF drainage.
Immediately after anesthesia, the patient was turned to the supine position where they remained for 15 min. The patients were given oxygen through nasal prongs at 3-5 L/min. The chart of sensory and motor block level and hemodynamic status was completed.
The median sensory nerve block levels were evaluated by the pinprick test in the midline region of the skin dermatomes using a 25-gauge Whitacre needle, and recorded according to the relevant dermatome. The sensory block levels were recorded every 5 min until 30 min after spinal anesthesia and then at 60 and 90 min. We recorded the maximum sensory block reached at each time point, the peak sensory block reached, the time required to achieve sensory block in T10, and the duration of sensory block at T10.
Peripheral oxygen saturation, arterial blood pressure, and heart rate were recorded every 5 min after the spinal anesthesia. Any incidence of hypotension or bradycardia was reported. A > 20% decrease in mean arterial pressure, triggered immediate administration of 5 mg of ephedrine. A heart rate < 50 beats/min, triggered immediate administration of 0.5 mg of atropine.
3.1. Ethical Considerations
The Ethics Committee of the Shahid Beheshti University of Medical Sciences approved this study. An anesthesiologist determined the need for spinal anesthesia and explained the study's details. Patients were enrolled only after signing an informed consent. Each solution (NS, R, and HES) has been legally approved for use, and they are routinely used before spinal anesthesia for the prevention of hypotension secondary to systemic vasodilatation, and hyperbaric bupivacaine. Because the evaluation of motor and sensory block levels are routine parts of any spinal anesthesia procedure there were no additional procedures necessary.
3.2. Statistical Analysis
Statistical analyses were performed using SPSS software (version 17; Chicago, USA). Analysis of variance (ANOVA), chi square (or Fisher’s exact) and Kruskal-Wallis tests were used to analyze the differences between groups. The comparisons were performed using a Bonferroni correction for continuous normally distributed variables and a Wilcoxon signed rank test with a Bonferroni correction for non-normally distributed data. For measures of anesthesia we used a linear mixed model. The incidence of hypotension and bradycardia between the three groups in the clinical study was compared using a chi square test. A P value less than 0.05 was considered significant.